You are logged in as: - | Logout

One community, over 5000 individuals with the same aim: Vaccine Safety.

2016

Results of the international study investigating the association of Influenza H1N1 Vaccine with narcolepsy are presented to the WHO Global Advisory Committee on Vaccine Safety. 

2015

GAIA Network for Global Alignment of Immunisation safety Assessment in pregnancy established. 

2015

Vaccine Module of European Joint Master Program in Paediatric Drug Development and Evaluation created and delivered. 

2013

Clinical Advisory Forum of Experts (CAFE) is launched as a real-time exchange platform for vaccine safety professionals worldwide

2013

Templates for documenting the safety of Viral Vector Vaccines created. 

2013

Brighton Collaboration Online Journal Club formalised to promote open and transparent scientific debate of current issues in vaccine safety. 

2012

Brighton Collaboration instrumental in building ADVANCE consortium. 

2012

The Vaccine Safety Quarterly provides news and information from the volunteering Brighton Collaboration network and reaches over 4000 members of the Brighton Collaboration.

2012

Vaccine.GRID established as independent foundation and dedicated platform for the conduct of large-scale international observational vaccine safety and benefit-risk studies. 

2012

International symposium on innovations in vaccine safety monitoring in Shanghai.

2012

Centers for Disease Control and Prevention (CDC) request worldwide study on narcolepsy (SOMNIA). 

2011

The Brighton Foundation US is registered in Boston, Massachusetts as a public charity and associated partner to the Brighton Collaboration Foundation, Switzerland.

2011

First ever international risk assessment study based on one protocol and one data sharing infrastructure published based on over 30 Million population: Guillain-Barre Syndrome following pandemic influenza H1N1 vaccine. 

2011

First ever international background rate studies based on one protocol and one data sharing infrastructure: A dozen adverse events of special interest based on over 260 Million person years. 

2011

World Health Organization (WHO) vaccine safety strategy (Vaccine Safety Blueprint) published. Brighton Collaboration was development partner. 

2010

Brighton Collaboration contributes to World Health Organization (WHO) Global Vaccine Safety Landscape Analysis. 

2009

Pilot of European Vaccine Safety Data Network launched on request of ECDC.

2009

General guidelines for the collection, analysis, and publication of vaccine safety data in surveillance systems and clinical trials. 

2008

First method for evaluating case definitions established and published. 

2008

Computer-based classification of adverse events is automated. The ABC-Tool is available on the website.

2008

The European Medicines Agency (EMA) recommends the use of Brighton Collaboration standards. 

2007

Food and Drug Administration (FDA) recommends the use of Brighton Collaboration case definitions. 

2006

European Center of Disease Prevention and Control (ECDC) joins as observer and funding agency. 

2006

American Academy of Pediatrics references the Brighton Collaboration in its infectious disease reference manual, the Redbook. 

2005

UN Council for International Organization of Medical Sciences (CIOMS) recommends the use of Brighton Collaboration case definitions and guidelines. 

2004

Foundation creates first online collaboration platform. 

2004

First scientific publications of the Brighton Collaboration including first six case definitions of adverse events following immunisation. 

2003

Brighton Collaboration Foundation is established as international NPO in Switzerland with an endowment of the University Children’s Hospital Basel (UKBB). 

2002

The network has become global with several hundred active participants coming from all continents. 

2001

The Brighton Method for defining adverse events following immunization was established. 

2000

Official launch meeting of the Brighton Collaboration in Verona. Kathrin Kohl, Centers for Disease Control and Prevention (CDC), and Jan Bonhoeffer, University Children’s Hospital Basel (UKBB) were appointed to build an international network and coordinate activities.

2000

WHO joins as observer and funding agency.

1999

Robert Chen called for improving the quality of vaccine safety data at a Vaccine Conference in Brighton, England. Harald Heijbel, Ulrich Heininger, Tom Jefferson, and Elisabeth Loupi joined to address this need.